Pierce Lori J, Moughan Jennifer, White Julia, Winchester David P, Owen Jean, Wilson J Frank
Department of Radiation Oncology, University of Michigan School of Medicine, Ann Arbor, MI 48109-0010, USA.
Int J Radiat Oncol Biol Phys. 2005 May 1;62(1):183-92. doi: 10.1016/j.ijrobp.2004.09.019.
The Patterns of Care Study survey process evaluation has been an effective means of assessing the evaluation and treatment practices used by radiation oncologists in the United States for Stage I-II breast cancer. The current 1998-1999 report updates the previous 1989 and 1993-1994 analyses and reflects the recent changes in surgery and systemic therapy observed nationally in the management of early-stage disease.
A weighted sample size of 71,877 patient records of women treated with breast-conserving surgery and radiotherapy (RT) was obtained from a stratified two-stage sampling of 353 patient records. These cases were centrally reviewed from academic and private radiation oncology practices across the United States. The data collected included patient characteristics, clinical and pathologic factors, and surgical and RT details. The results were compared with those of previous Patterns of Care Study survey reports.
Of the patients in the current survey, 97% had undergone mammography before biopsy. A review of the primary tumor pathologic findings indicated improved quantification of an intraductal component from 7.0% in 1993-1994 to 20.4% in 1998-1999 (p = 0.01). The tumor characteristics were better defined, with estrogen and progesterone receptor measurement performed in 91.4% and 91.3% in the 1998-1999 survey vs. 83.7% and 80.3% in the 1989 survey, respectively (p = 0.03 and p = 0.002, respectively). Axillary dissection was performed in 82.2% in the present survey compared with 93.6% in the 1993-1994 survey (p = 0.0004); sentinel node biopsy was performed in 20.1% of the present cases. The use of CT for planning was increased in the current survey, with 22.9% cases CT planned vs. 9% in 1993-1994 (p = 0.10). In the present survey, 100% had received whole breast RT. When a supraclavicular field was added, the dose was prescribed to a specified depth in 67.5% of cases, most commonly 3 cm. When an axillary field was added, the dose was generally prescribed to the mid-plane. Chemotherapy and tamoxifen was used in 36% and 55.8% of patients, respectively, in the 1998-1999 survey, representing a statistically significant increase compared with the 1993-1994 survey, despite comparable pathologic tumor size and nodal involvement.
The present results demonstrate a high level of compliance of the sampled radiation oncology practices with current breast conservation standards and continued improvement in many categories compared with prior patterns of care study surveys. The estimates in the current survey after whole breast RT will serve as a benchmark against newer trends in breast cancer RT, such as partial breast RT.
“治疗模式研究”调查过程评估一直是评估美国放射肿瘤学家对I-II期乳腺癌的评估和治疗实践的有效手段。当前的1998 - 1999年报告更新了之前1989年以及1993 - 1994年的分析,并反映了全国范围内早期疾病管理中观察到的手术和全身治疗的最新变化。
从353份患者记录的分层两阶段抽样中获得了71,877份接受保乳手术和放疗(RT)的女性患者记录的加权样本量。这些病例由美国各地的学术和私立放射肿瘤学实践进行集中审查。收集的数据包括患者特征、临床和病理因素以及手术和放疗细节。将结果与之前的“治疗模式研究”调查报告进行比较。
在本次调查的患者中,97%在活检前进行了乳房X线摄影。对原发性肿瘤病理结果的审查表明,导管内成分的量化有所改善,从1993 - 1994年的7.0%提高到1998 - 1999年的20.4%(p = 0.01)。肿瘤特征得到了更好的界定,1998 - 1999年调查中分别有91.4%和91.3%的患者进行了雌激素和孕激素受体检测,而1989年调查中这一比例分别为83.7%和80.3%(p分别为0.03和0.002)。本次调查中82.2%的患者进行了腋窝清扫,而1993 - 1994年调查中这一比例为93.6%(p = 0.0004);20.1%的当前病例进行了前哨淋巴结活检。在本次调查中,使用CT进行治疗计划的比例有所增加,22.9%的病例采用CT计划,而1993 - 1994年为9%(p = 0.10)。在本次调查中,100%的患者接受了全乳放疗。当添加锁骨上野时,67.5%的病例将剂量规定到特定深度,最常见的是3 cm。当添加腋窝野时,剂量通常规定到中平面。在1998 - 1999年调查中,分别有36%和55.8%的患者使用了化疗和他莫昔芬,与1993 - 1994年调查相比有统计学显著增加,尽管病理肿瘤大小和淋巴结受累情况相当。
目前的结果表明,抽样的放射肿瘤学实践与当前的保乳标准高度符合,并且与之前的治疗模式研究调查相比,在许多方面持续改善。本次全乳放疗后的调查估计将作为乳腺癌放疗新趋势(如部分乳腺放疗)的基准。